The saturation of the domestic market with domestic medicines, increasing their share in the total volume of pharmaceutical products and expanding exports. The international scientific-practical conference "Belarusian medicines" has started in the capital.
Among the participants, there are specialists and scientists from Belarus and Russia, representatives of medical institutions and pharmaceutical companies of the country. The agenda includes modern technologies for producing drugs and studying their activity.
The main target is correction of oncological, infectious and cardiovascular diseases. Upon the instructions of the head of state, special attention is paid to import substitution.
Vasily Gursky, Chief Scientific Secretary of the National Academy of Sciences of Belarus:
"Almost all our developments are aimed at producing our own high-tech products in our country. This conference is a demonstration event where the real results of our scientific activity are demonstrated. In particular, these are antitumor and other drugs based on domestic substances.
Vladimir Levashkevich, Deputy Academician-Secretary of the Department of Chemistry and Earth Sciences of the National Academy of Sciences of Belarus:
The researches of the Institute of Bioorganic Chemistry are mainly targeted at the development of antitumor drugs and not just development, but scientific research, development and production of pharma-substances, development and production of drugs and their provision to the market. The main efforts of Belarusian companies are also aimed at creating a domestic vaccine. It is planned to present it by 2023. The results of the conference will be announced on Friday.
International scientific-practical conference "Belarusian medicines" takes place in Minsk
23 ноября 2022












